基础医学与临床 ›› 2023, Vol. 43 ›› Issue (10): 1530-1536.doi: 10.16352/j.issn.1001-6325.2023.10.1530

• 研究论文 • 上一篇    下一篇

丙泊酚促进绝经后骨质疏松大鼠血管生成

赵晓琦1, 董鑫1, 刘聪1, 任鹏程1, 张亮2*   

  1. 1.空军军医大学第二附属医院 麻醉科,陕西 西安 710016;
    2.西安航天总医院 麻醉科, 陕西 西安 710100
  • 收稿日期:2023-03-13 修回日期:2023-06-01 出版日期:2023-10-05 发布日期:2023-10-05
  • 通讯作者: *874900233@qq.com
  • 基金资助:
    陕西省2022年科技计划项目(2022SF-521)

Propofol promotes angiogenesis in rats with postmenopausal osteoporosis

ZHAO Xiaoqi1, DONG Xin1, LIU Cong1, REN Pengcheng1, ZHANG Liang2*   

  1. 1. Department of Anesthesiology, the Second Hospital Affiliated to Air Force Medical University, Xi'an 710016;
    2. Department of Anesthesiology, Xi'an Aerospace General Hospital, Xi'an 710100, China
  • Received:2023-03-13 Revised:2023-06-01 Online:2023-10-05 Published:2023-10-05
  • Contact: *874900233@qq.com

摘要: 目的 研究丙泊酚对绝经后骨质疏松症(PMOP)大鼠血管生成的影响及Wnt/β-连环蛋白(β-catenin)信号通路的作用。方法 将大鼠随机分为假手术组、PMOP组(切除双侧卵巢)、丙泊酚2.5 mg/kg和5.0 mg/kg组和丙泊酚+Wnt抑制剂组(丙泊酚5.0 mg/kg+2 mg/kg Wnt抑制剂),每组10只。酶联免疫吸附(ELISA)法检测血清中骨碱性磷酸酶(BALP)、骨保护素(OPG)、核因子κB受体活化因子配体(RANKL)、血管内皮细胞生长因子(VEGF)、促血管生成素-1(Ang-1)水平;双能X线骨密度仪测定股骨骨密度(BMD);苏木精-伊红(HE)染色观察骨组织病理形态学;免疫组化和Western blot分别检测骨组织中CD31阳性表达及骨形态发生蛋白-2(BMP-2)、Runt相关转录因子2(Runx2)、VEGFA、CD31、Wnt2、磷酸化糖原合酶激酶-3β(p-GSK-3β)、β-catenin蛋白表达。结果 与假手术组比较,PMOP组大鼠血清RANKL水平升高(P<0.05),BALP、OPG、VEGF、Ang-1水平、股骨BMD及骨组织中CD31阳性表达和BMP-2、Runx2、VEGFA、CD31、Wnt2、p-GSK-3β、β-catenin蛋白表达降低(P<0.05),骨小梁受损且髓腔扩大;与PMOP组比较,丙泊酚组和丙泊酚+Wnt抑制剂组大鼠上述指标变化明显缓解(P<0.05);与丙泊酚5.0 mg/kg组比较,丙泊酚+Wnt抑制剂组可抑制Wnt/β-catenin信号通路激活,并减弱了丙泊酚对PMOP大鼠血管生成、骨代谢调节和骨组织形态改善的促进作用(P<0.05)。结论 丙泊酚可能通过激活Wnt/β-catenin信号通路促进PMOP大鼠血管生成,调节骨代谢,发挥抗PMOP作用。

关键词: 绝经后骨质疏松症, 血管生成, 丙泊酚, Wnt/β-catenin信号通路

Abstract: Objective To investigate the impact of propofol on angiogenesis in postmenopausal osteoporosis (PMOP) rats and the role of Wnt/β-catenin signal pathway in this process. Methods Female Wistar rats were randomly grouped into sham operation group, PMOP group (bilateral ovariectomy), groups of propofol 2.5 mg/kg and of 5.0 mg/kg and propofol+Wnt inhibitor group (propofol 2.5 mg/kg + Wnt inhibitor 2 mg/kg), with 10 rats in each. The serum level of bone alkaline phosphatase (BALP), osteoprotegerin (OPG), nuclear factor κB receptor activating factor ligand (RANKL), vascular endothelial growth factor (VEGF) and angiopoietin-1 (Ang-1) was detected by enzyme linked immunosorbent assay (ELISA); bone mineral density (BMD) of femur was measured by dual-energy X-ray absorptiometry; hematoxylin-eosin (HE) staining microscopy was applied to observe pathological changes of bone tissue; the expression of CD31 in bone tissue was detected by immunohistochemistry; Western blot was applied to detect the expression of bone morphogenetic protein-2 (BMP-2), runt-related transcription factor 2 (Runx2), VEGFA, CD31, Wnt2, phosphorylated glycogen synthase kinase-3 (p-GSK-3) and β-catenin in bone tissue. Results Compared with the sham operation group, the serum RANKL level of PMOP group increased, the level of BALP, OPG, VEGF, Ang-1, expression of CD31 and protein level of BMP-2, Runx2, VEGFA, CD31, Wnt2, p-GSK-3, β-catenin all decreased (P<0.05), the bone trabecula was damaged and the medullary cavity was enlarged; compared with the PMOP group, the changes of the above indexes in the propofol groups and the propofol+Wnt inhibitor group were obviously relieved(P<0.05); compared with the propofol 5.0 mg/kg group, the propofol+Wnt inhibitor group showed inhibition in the activation of Wnt/β-catenin signal pathway, and weaken the promotion of propofol on angiogenesis, bone metabolism regulation and bone tissue morphology improvement in PMOP rats(P<0.05). Conclusions Propofol may promote angiogenesis and regulate bone metabolism in PMOP rats by activating Wnt/β-catenin signal pathway as the potential mechanisms involved in anti-PMOP role process.

Key words: postmenopausal osteoporosis, angiogenesis, propofol, Wnt/β-catenin signal pathway

中图分类号: